# Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction

> **NCT01562353** · — · UNKNOWN · sponsor: **Analgesic Solutions** · enrollment: 30 (estimated)

## Conditions studied

- Usage of Prescription Opioids

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01562353
- **Lead sponsor:** Analgesic Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01562353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01562353, "Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction". Retrieved via MORVS 2026-11-21 from https://api.morvs.ai/clinical/NCT01562353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
